All information you are about to see is related to a specific selected market, including the products’ portfolio, and therefore comply to different local regulations.

NEWSROOM

Corporate

10/02/2023

Fidia Farmaceutici Enters The Polish Market

Corporate

10/05/2022

Regenerate & Evolve: Fidia Farmaceutici goes online with its new digital brand identity

Corporate

13/10/2021

Fidia celebrates its 75th anniversary: not a destination, but just one leg of a journey that is going faster than ever

Research

26/07/2021

Fidia announces the FDA orphan drug designation for Oncofid for the treatment of malignant mesothelioma